BioSpace News Archive

Press Releases

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for Cranial Flap Fixation

December 12, 2024
·
2 min read
Press Releases

DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

December 12, 2024
·
11 min read
Press Releases

Bristol Myers Squibb Announces Dividend Increase

December 12, 2024
·
1 min read
Press Releases

Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million

December 12, 2024
·
3 min read
Press Releases

Fonseca Biosciences Secures Exclusive US Rights to XTORO® (finafloxacin otic suspension) 0.3% to Treat Swimmer’s Ear

December 12, 2024
·
2 min read
Press Releases

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

December 12, 2024
·
10 min read
Press Releases

KIND Presents Preclinical Results of AND017 in Animal Models of Sickle Cell Disease (SCD), Myelodysplastic Syndromes (MDS), and β-Thalassemia at the 66th American Society of Hematology Meeting and Exposition and Announces FDA Authorization of Investigational New Drug (IND) Application for AND017 for Clinical Trial in Sickle Cell Disease (SCD)

December 12, 2024
·
5 min read
Press Releases

Corcept Announces Results From Phase 2 Study of Dazucorilant in Patients With Amyotrophic Lateral Sclerosis (ALS)

December 12, 2024
·
3 min read
Press Releases

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

December 12, 2024
·
16 min read
Press Releases

Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody checkpoint inhibitor

December 12, 2024
·
3 min read